Aortic regurgitation: Difference between revisions
mNo edit summary |
|||
Line 30: | Line 30: | ||
==[[Aortic Regurgitation Pathophysiology|Pathophysiology]]== | ==[[Aortic Regurgitation Pathophysiology|Pathophysiology]]== | ||
==Diagnosis== | ==Diagnosis== |
Revision as of 14:40, 19 March 2011
For patient information click here
Aortic regurgitation | |
Aortic Valve Insufficiency: Gross, mitral and aortic valve calcification with partially ruptured cusp. Aortic insufficiency with nice kangaroo pouches. (An excellent example). Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editors-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Keri Shafer, M.D. [3]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [4] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Synonyms and related words: Aortic regurgitation, AI, AR
Aortic Insufficiency refers to retrograde or backwards flow of blood from the aorta into the left ventricle during diastole.[1] [2] [3] [4]
Epidemiology
Pathophysiology
Diagnosis
Differential Diagnosis
Symptoms
Physical findings
Electrocardiogram
Chest x-ray
Echocardiography
Aortography
Treatment
Overview
Medical Management
Surgical Treatment
Complications and Prognosis
References
- ↑ Connolly HM, Crary JL, McGoon MD; et al. (1997). "Valvular heart disease associated with fenfluramine-phentermine". N. Engl. J. Med. 337 (9): 581–8. doi:10.1056/NEJM199708283370901. PMID 9271479.
- ↑ Weissman NJ (2001). "Appetite suppressants and valvular heart disease". Am. J. Med. Sci. 321 (4): 285–91. doi:10.1097/00000441-200104000-00008. PMID 11307869.
- ↑ Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007). "Dopamine agonists and the risk of cardiac-valve regurgitation". N. Engl. J. Med. 356 (1): 29–38. doi:10.1056/NEJMoa062222. PMID 17202453.
- ↑ Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007). "Valvular heart disease and the use of dopamine agonists for Parkinson's disease". N. Engl. J. Med. 356 (1): 39–46. doi:10.1056/NEJMoa054830. PMID 17202454.
External links
- Heart Disease and Life After by Richard Hinkle
See also
Acknowledgments
Person who first created this page was Editor-In-Chief: C. Michael Gibson, M.S., M.D. [5]